Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

66.42
Delayed Data
As of Jul 31
 +4.62 / +7.48%
Today’s Change
57.95
Today|||52-Week Range
121.95
-25.08%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 89.00, with a high estimate of 106.00 and a low estimate of 69.00. The median estimate represents a +34.00% increase from the last price of 66.42.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.01
Sales
$61.1M
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually 164.47%
 
 
 
 
 
 

Sales

Growthquarterly 3.30%
 
 
 
 
 
 
Growthannually 24.33%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.